261 related articles for article (PubMed ID: 24573553)
21. Feasibility Study of Single-Photon Emission Computed Tomography with Iodine-123 Labeled Metaiodobenzylguanidine for Preclinical Evaluation of Labetalol as a β-Adrenergic Receptor Blocker.
Choi Y; Lee ES; Woo SK; Lee KC; Chung HK; Kang JH
Mol Pharm; 2024 May; 21(5):2435-2440. PubMed ID: 38626389
[TBL] [Abstract][Full Text] [Related]
22. Improved resolution and sensitivity of [
Pauwels E; Celen S; Vandamme M; Leysen W; Baete K; Bechter O; Bex M; Serdons K; Van Laere K; Bormans G; Deroose CM
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):313-315. PubMed ID: 32385645
[No Abstract] [Full Text] [Related]
23. Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[
Lokitz SJ; Garg S; Nazih R; Garg PK
Mol Imaging Biol; 2019 Aug; 21(4):686-695. PubMed ID: 30250991
[TBL] [Abstract][Full Text] [Related]
24. Novel [
Li X; Shi S; Zhou H; Zhao Z; Lu J
Mol Pharm; 2021 Oct; 18(10):3811-3819. PubMed ID: 34519204
[TBL] [Abstract][Full Text] [Related]
25. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Melzer HI; Coppenrath E; Schmid I; Albert MH; von Schweinitz D; Tudball C; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1648-58. PubMed ID: 21617976
[TBL] [Abstract][Full Text] [Related]
26. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
27. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP
Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627
[TBL] [Abstract][Full Text] [Related]
28. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
[TBL] [Abstract][Full Text] [Related]
29. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
Rutgers M; Buitenhuis CK; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Aug; 87(3):412-22. PubMed ID: 10897048
[TBL] [Abstract][Full Text] [Related]
30. Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
Chen X; Fritz A; Werner RA; Nose N; Yagi Y; Kimura H; Rowe SP; Koshino K; Decker M; Higuchi T
Mol Imaging Biol; 2020 Jun; 22(3):602-611. PubMed ID: 31332629
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
32. PET imaging of norepinephrine transporter-expressing tumors using 76Br-meta-bromobenzylguanidine.
Watanabe S; Hanaoka H; Liang JX; Iida Y; Endo K; Ishioka NS
J Nucl Med; 2010 Sep; 51(9):1472-9. PubMed ID: 20720048
[TBL] [Abstract][Full Text] [Related]
33. Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.
Samim A; Tytgat GAM; Bleeker G; Wenker STM; Chatalic KLS; Poot AJ; Tolboom N; van Noesel MM; Lam MGEH; de Keizer B
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33916640
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of
Das S; Sakhare N; Mathur A; Mallia MB; Mirapurkar S; Sheela M; Sarma HD; Sachdev SS; Dash A
Nucl Med Biol; 2019; 68-69():49-57. PubMed ID: 30770228
[TBL] [Abstract][Full Text] [Related]
35. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.
Brader P; Kelly KJ; Chen N; Yu YA; Zhang Q; Zanzonico P; Burnazi EM; Ghani RE; Serganova I; Hricak H; Szalay AA; Fong Y; Blasberg RG
Clin Cancer Res; 2009 Jun; 15(11):3791-801. PubMed ID: 19470726
[TBL] [Abstract][Full Text] [Related]
36. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.
Anton M; Wagner B; Haubner R; Bodenstein C; Essien BE; Bönisch H; Schwaiger M; Gansbacher B; Weber WA
J Gene Med; 2004 Jan; 6(1):119-26. PubMed ID: 14716684
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and preliminary evaluation of para- and meta-[18F]fluorobenzylguanidine.
Garg PK; Garg S; Zalutsky MR
Nucl Med Biol; 1994 Jan; 21(1):97-103. PubMed ID: 9234270
[TBL] [Abstract][Full Text] [Related]
38. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
[TBL] [Abstract][Full Text] [Related]
39. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
[TBL] [Abstract][Full Text] [Related]
40.
Kitamura Y; Baba S; Isoda T; Maruoka Y; Sasaki M; Kamitani T; Koga Y; Kawakubo N; Matsuura T; Ishigami K
Ann Nucl Med; 2021 May; 35(5):549-556. PubMed ID: 33586098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]